miRNA-133b and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling pathway in human renal carcinoma cells

被引:57
作者
Zhou, Wenbin [1 ]
Bi, Xingjie [2 ]
Gao, Guojun [3 ]
Sun, Lijiang [4 ]
机构
[1] Hosp Weifang Med Univ, Dept Surg, Weifang 261053, Peoples R China
[2] Weifang Fifth Peoples Hosp, Dept Dermatol, Weifang 261061, Peoples R China
[3] Weifang Med Univ, Affiliated Hosp, Dept Urol, Weifang 261031, Peoples R China
[4] Qingdao Univ, Affiliated Hosp, Dept Urol, Qingdao 266003, Peoples R China
关键词
miR-133b; miR-135a; ccRCCs; JAK2; STAT3; Apoptosis; GASTROINTESTINAL STROMAL TUMORS; DOWN-REGULATION; GASTRIC-CANCER; EXPRESSION; KIT; PROLIFERATION; INHIBITION; MIR-222; TRANSCRIPTION; RESISTANCE;
D O I
10.1016/j.biopha.2016.09.074
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aberrantly expressed microRNAs (miRNAs) are involved in many diseases including cancer. In clear cell renal cell carcinoma (ccRCCs) expression of miR-133b and miR-135a is reduced compared to control tissue and other sarcomas but the functional effects of this downregulation are not fully understood. This study aimed at evaluating the miR-133b and miR-135a expression profiles in different RCC subtypes and the functional role of these miRNAs. Viability and apoptosis were examined in three different ccRCC cell lines (786-O, A498 and SN12-PM6) after over-expression of these miRNAs. The modulation of JAK2 and the JAK2/STAT3 pathways was determined by Western blot. Transient transfection of miR-133b and miR-135a reduced viability and induced apoptosis by inhibition of JAK2 expression and its phosphorylation and activation of caspase 3 and 7 in all three ccRCC cell lines. p-STAT3 and Bcl-2 expression was reduced after miRNA transfection whereas only slight influence on Bcl-2 L11 (BIM) was detected. Our results demonstrate that miR-133b and miR-135a which are down-regulated in wildtype and mutated ccRCCs, induce apoptosis in vitro by a signaling cascade involving JAK2, STAT3 and Bcl-2. Therefore, overexpression of these miRNAs seems to functionally counteract oncogenic signalling pathways in ccRCCs. (C) 2016 Published by Elsevier Masson SAS.
引用
收藏
页码:722 / 729
页数:8
相关论文
共 43 条
[1]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[2]   The microRNA.org resource: targets and expression [J].
Betel, Doron ;
Wilson, Manda ;
Gabow, Aaron ;
Marks, Debora S. ;
Sander, Chris .
NUCLEIC ACIDS RESEARCH, 2008, 36 :D149-D153
[3]   Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group [J].
Debiec-Rychter, M ;
Dumez, H ;
Judson, I ;
Wasag, B ;
Verweij, J ;
Brown, M ;
Dimitrijevic, S ;
Sciot, R ;
Stul, M ;
Vranck, H ;
Scurr, M ;
Hagemeijer, A ;
Van Glabbeke, M ;
van Oosterom, AT .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (05) :689-695
[4]   MicroRNA-induced drug resistance in gastric cancer [J].
Dehghanzadeh, Rashedeh ;
Jadidi-Niaragh, Farhad ;
Gharibi, Tohid ;
Yousefi, Mehdi .
BIOMEDICINE & PHARMACOTHERAPY, 2015, 74 :191-199
[5]  
Demetri GD, 2010, J NATL COMPR CANC NE, V8, pS1
[6]   Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs) [J].
Duensing, A ;
Medeiros, F ;
McConarty, B ;
Joseph, NE ;
Panigrahy, D ;
Singer, S ;
Fletcher, CDM ;
Demetri, GD ;
Fletcher, JA .
ONCOGENE, 2004, 23 (22) :3999-4006
[7]   Therapeutic potential for microRNAs [J].
Esau, Christine C. ;
Monia, Brett P. .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (2-3) :101-114
[8]   MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation [J].
Felli, N ;
Fontana, L ;
Pelosi, E ;
Botta, R ;
Bonci, D ;
Facchiano, F ;
Liuzzi, F ;
Lulli, V ;
Morsilli, O ;
Santoro, S ;
Valtieri, M ;
Calin, GA ;
Liu, CG ;
Sorrentino, A ;
Croce, CM ;
Peschle, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (50) :18081-18086
[9]   Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3 [J].
Gan, R. ;
Yang, Y. ;
Yang, X. ;
Zhao, L. ;
Lu, J. ;
Meng, Q. H. .
CANCER GENE THERAPY, 2014, 21 (07) :290-296
[10]   Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31 [J].
Haller, Florian ;
von Heydebreck, Anja ;
Zhang, Jitao David ;
Gunawan, Bastian ;
Langer, Claus ;
Ramadori, Giuliano ;
Wiermann, Stefan ;
Sahin, Oezguer .
JOURNAL OF PATHOLOGY, 2010, 220 (01) :71-86